Collabera · 1 week ago
Regulatory Specialist
Collabera is seeking a Regulatory Specialist-Scientific Writer to draft high-quality reports for Crop Protection regulatory submissions. The role requires strong scientific writing skills and a background in chemistry, along with responsibilities that include quality control reviews and stakeholder communication.
Responsibilities
Draft high-quality Product Chemistry study reports and study summaries to support Crop Protection regulatory submissions
Perform quality control reviews on draft reports and/or raw data
Assist in developing new report templates, optimize processes, and assess stakeholder feedback for continuous improvement
Facilitate finalization of reports and audit responses
Communicate effectively with key stakeholders and customers
Partnership with stakeholders and customers to understand regulatory reporting requirements is important for success
Qualification
Required
Bachelor's degree or higher in Chemistry, Biochemistry, or a related scientific discipline
Demonstrated experience in scientific writing, preferably within the regulatory or crop protection industry
Strong understanding of Good Laboratory Practice (GLP) standards and regulatory guidelines
Excellent attention to detail and ability to perform quality control reviews on scientific documents and raw data
Effective communication and collaboration skills with cross-functional teams and stakeholders
Ability to manage multiple projects simultaneously and meet tight deadlines
Benefits
Medical insurance
Dental insurance
Vision insurance
401(k) retirement plan
Life insurance
Long-term disability insurance
Short-term disability insurance
Paid parking/public transportation
Paid time off
Days/hours of paid sick and safe time
Days/hours of paid vacation time
Weeks of paid parental leave
Paid holidays annually
Any additional benefits applicable
Company
Collabera
Collabera is an end-to-end information technology services and solutions provider helping clients align their business and IT strategies.
Funding
Current Stage
Late StageTotal Funding
$30M2006-05-04Series Unknown· $30M
Recent News
2024-04-09
2023-01-20
2022-04-19
Company data provided by crunchbase